Fig. 4

Haplotype phasing of pathogenic alleles containing the c.5098G > C (p.Glu1700Gln) and c.5975A > G (p.Lys1992Arg) variants. Long-read sequencing (LRS) was performed on the Oxford Nanopore Technologies (ONT) platform for samples (A) DE4777, (B) DE4886, and (C) DE5604. Phased haplotypes, designated as allele 1 and allele 2, were determined based on the presence of c.5098G > C (p.Glu1700Gln) (right) and the respective compound heterozygous variants (middle)